中华交易服务香港生物科技指数上涨4.86%，前十大权重包含百济神州等

Group 1 - The core index of the China Securities Exchange Service Hong Kong Biotechnology Index (CESHKB) rose by 4.86%, closing at 5646.67 points with a trading volume of 10.416 billion [1] - Over the past month, the CESHKB has decreased by 1.72%, but it has increased by 28.09% over the last three months and by 20.18% year-to-date [1] - The CESHKB is designed to reflect the overall performance of biotechnology companies listed in Hong Kong, with a base date of December 12, 2014, and a base point of 2000.0 [1] Group 2 - The top ten holdings of the CESHKB include: CanSino Biologics (11.2%), Innovent Biologics (10.58%), BeiGene (10.28%), WuXi Biologics (9.54%), China National Pharmaceutical Group (9.18%), Zai Lab (5.76%), 3SBio (5.37%), Kelun-Biotech (4.59%), WuXi AppTec (4.46%), and Genscript Biotech (3.47%) [1] - The CESHKB is fully composed of stocks listed on the Hong Kong Stock Exchange, with a sector breakdown showing that biopharmaceuticals account for 60.95%, pharmaceutical and biotechnology services for 22.57%, chemical drugs for 12.94%, and medical devices for 3.53% [2]